{
    "2018-06-12": [
        [
            {
                "time": "2018-06-12",
                "original_text": "大盘难持续下跌，中期布局消费与成长",
                "features": {
                    "keywords": [
                        "大盘",
                        "消费",
                        "成长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "消费",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "长生生物：四价流感疫苗获批生产，下半年开始贡献业绩",
                "features": {
                    "keywords": [
                        "长生生物",
                        "四价流感疫苗",
                        "业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "华兰生物：子公司获批文，四价流感病毒裂解疫苗可正式生产和销售",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "生产和销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "国内首个四价流感疫苗获批上市！市场或超四价HPV疫苗",
                "features": {
                    "keywords": [
                        "四价流感疫苗",
                        "HPV疫苗",
                        "市场潜力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "格力集团终止要约收购长园集团，华兰生物四价流感疫苗可正式生产",
                "features": {
                    "keywords": [
                        "格力集团",
                        "长园集团",
                        "华兰生物",
                        "四价流感疫苗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物",
                        "家电制造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "创新药盘点系列报告（7）：四价流感疫苗：百亿市场潜力",
                "features": {
                    "keywords": [
                        "创新药",
                        "四价流感疫苗",
                        "百亿市场"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "华兰生物:四价流感疫苗获批生逢其时，打造国内最宽流感疫苗产品线",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "产品线"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}